AurKa Pharma's Acquisition

AurKa Pharma was acquired by Eli Lilly & Co. on May 14, 2018.

AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Ventures VII. To date, the biopharmaceutical asset has …

Articles about AurKa Pharma's Acquisition: